$TEM
1 analysts · 0 active debates

Tempus AI, Inc. TEM

Currently 1 bullish, 0 bearish — stable.

Analysts are holding steady at 1 bullish to 0 bearish.

1 YouTube analyst covers Tempus AI, Inc. (TEM).

1 analyst has covered TEM so far…

Analyst opinions

Analyst opinions

AI data platform drives diagnostics growth

Tempest (TEM) is a compelling AI-driven healthcare data platform with massive proprietary biological datasets and accelerating diagnostics revenue, but I won’t buy more because my biotech allocation is already too large.

Tempest is characterized as a compelling AI-driven healthcare data platform with massive proprietary biological datasets and accelerating diagnostics revenue. The bullish view is qualified only by portfolio allocation constraints, not by any fundamental concern.

3mo
"Nancy Pelosi Just Purchased 6 New Stocks in 2026!"

promising precision oncology, high execution risk

Tempest AI (TEM) combines massive clinical/molecular datasets with diagnostics and precision-medicine AI, showing strong revenue growth and improved margins, but remains a high-risk, high-reward biotech that I view as likely headed in the right direction.

Tempest AI's massive clinical and molecular datasets, strong revenue growth, and improving margins in precision diagnostics point in the right direction, but the business remains a high-risk biotech where commercial and regulatory execution risk stays elevated.

6mo
"5 Stocks Google is BUYING NOW!"

No official filings surfaced for TEM yet.